A PYMNTS Company

US: California insurance chief urges Aetna-Humana deal blocked

 |  June 23, 2016

California’s insurance commissioner on Thursday urged national antitrust regulators to block health insurer Aetna Inc’s proposed $34 billion acquisition of Humana.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    David Jones, whose state Department of Insurance does not have authority to block the deal, said the acquisition would be anti-competitive in California and nationwide and contribute to higher prices for insurance.

    Jones’ comments came just days after California’s other insurance regulator said it had approved the Aetna-Humana deal with conditions, including that Aetna keep down premium increases and invest $50 million in communities.

    “We received approval earlier this week from the California Department of Managed Health Care, the only regulatory agency in the state with official oversight of our acquisition,” Aetna spokesman T.J. Crawford said.

    Jones a week ago also called for the U.S. Justice Department to stand against Anthem Inc’s proposed acquisition of Cigna Corp. He said that one of his concerns is the shrinking number of commercial insurers available to enter new markets.

    “If Humana disappears into this merger, it’s one less company that has the realistic possibility of entering the market,” Jones said.

    He said the agreement reached between Aetna and the California Department of Managed Health Care did not address antitrust concerns detailed in a 24-page letter his insurance department sent to the U.S. Department of Justice.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.